交易 Capricor Therapeutics Inc - CAPR CFD

Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases. The company''s lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase II clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with COVID-19; and completed various trials investigating the use of CAP-1002 for the treatment of cardiac conditions, including heart failure and post myocardial infarction with cardiac dysfunction. It is also developing CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in preclinical stage for the potential prevention of COVID-19. Capricor collaborates with Lonza Houston, Inc. for the development of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in Beverly Hills, California.

最新股票文章

美國對中關稅生效後,如何交易那斯達克100指數?
美國對中關稅生效後,如何交易那斯達克100指數?
上週四的跌勢尚未完全回補,但在部分科技巨頭股價強勁反彈帶動下,美股情緒明顯回暖,投資人情緒仍以多頭偏好為主。
07:48, 7 8月 2025
中國的經濟危機比想像中還嚴重?
中國的經濟危機比想像中還嚴重?
中國經濟正面臨嚴峻困境,而這張圖清楚說明了原因。圖表顯示中國的房地產投資、新開工項目以及房屋銷售的表現。
16:41, 27 7月 2025
特斯拉財報不及預期後的交易動向
特斯拉財報不及預期後的交易動向
第二季財報盈餘與營收皆未達預期,股價在盤後交易下跌,執行長馬斯克警告可能將面臨「幾個艱難的季度」
20:07, 24 7月 2025
為何麥可·貝利(Michael Burry)剛清倉所有股票?
為何麥可·貝瑞(Michael Burry)剛剛清倉所有股票
麥可·貝瑞剛剛拋售了超過7,000萬美元的股票,清空了他的整個投資組合,只保留一支股票,並對這家公司加碼,而其他投資人則紛紛出逃。
18:37, 22 7月 2025